Background Oncolytic virotherapy (OV) is an immunotherapy that incorporates viral cancer cell lysis with engagement of the recruited immune response against cancer cells. Pediatric solid tumors are challenging targets because they contain both an inert immune environment and a quiet antigenic landscape. making them more resistant to conventional OV approaches. Further complicating this. https://www.parisnaturalfoodes.shop/product-category/halva-vanilla/